Trade Summary

5 months ago, Gv 2021 Gp, L.L.C., serving as 10% owner at Prime Medicine, Inc. (PRME), purchased 1,500,000 shares at $3.30 per share, for a total transaction value of $4,950,000.00. Following this transaction, Gv 2021 Gp, L.L.C. now holds 3,262,440 shares of PRME.

This purchase represents a 85.00% increase in Gv 2021 Gp, L.L.C.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 1, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, August 5, 2025, 4 days after the trade was made.

Prime Medicine, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.